1 gen 2001 anni - Imatinib Mesylate
Descrizione:
Results of a clinical trial show that the drug imatinib mesylate is effective against chronic myelogenous leukemia (CML), which targets a unique protein produced by the Philadelphia chromosome.
Aggiunto al nastro di tempo:
Data: